HeartFlow Analysis vs Viz RV/LV
AI Verdict
Choose HeartFlow Analysis if…
Choose HeartFlow Analysis if you require a comprehensive, non-invasive assessment of coronary artery disease (CAD) to guide treatment decisions. This tool excels at providing detailed, personalized 3D models of coronary arteries, including fractional flow reserve (FFRct) and plaque characteristics, to determine the functional significance of blockages and inform revascularization strategies. It is ideal for evaluating patients with suspected or known CAD to optimize management plans.
View HeartFlow Analysis →Choose Viz RV/LV if…
Choose Viz RV/LV if your primary need is rapid and automated risk stratification for suspected pulmonary embolism (PE) in an acute care setting. This AI algorithm quickly measures right and left ventricular diameters from CTPA scans to provide a crucial RV/LV ratio, enabling swift identification of patients with right ventricular strain. It is best suited for emergency departments and critical care teams needing immediate insights and enhanced care coordination for PE management.
View Viz RV/LV →Reviewed by Pouyan Golshani, MD — Interventional Radiologist
Quick Comparison
| Feature | HeartFlow Analysis | Viz RV/LV |
|---|---|---|
| Pricing | Contact vendor for pricing | Unknown |
| Deployment | Cloud-based (AWS) | Cloud-based |
| BAA Available | Yes AI-estimated | Unknown |
| FDA Status | Cleared AI-estimated | Cleared AI-estimated |
Head-to-Head
AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.
Usability
Viz RV/LVViz RV/LV emphasizes rapid deployment, automated alerts, and mobile access to DICOM images, which streamlines communication and accelerates decision-making in acute settings. This focus on immediate, integrated workflow for urgent care scenarios suggests a higher degree of usability for its target application compared to HeartFlow's detailed 3D modeling and analysis.
Clinical Value
HeartFlow AnalysisHeartFlow Analysis provides a comprehensive, non-invasive physiological assessment for coronary artery disease (CAD) through FFRct and plaque analysis, which has been extensively validated to improve patient outcomes by reducing unnecessary invasive procedures and guiding revascularization decisions. While Viz RV/LV offers crucial rapid risk stratification for pulmonary embolism, HeartFlow's impact on complex treatment pathways for a chronic condition demonstrates a profound clinical value.
Pricing & Value
HeartFlow AnalysisHeartFlow Analysis clearly outlines its reimbursement model, including established Category I CPT codes and CMS payment rates, and is covered by Medicare and most U.S. commercial payers. This transparency and established reimbursement pathway significantly de-risk adoption for healthcare providers and demonstrate a clear economic value. Viz RV/LV lacks publicly available pricing or detailed reimbursement information, making its financial value proposition less clear.
Enterprise Readiness
TieBoth tools demonstrate strong enterprise readiness, being FDA-cleared, HIPAA-compliant, offering BAA agreements, and deploying via cloud-based infrastructure from established companies. There are no distinguishing factors in the provided information to determine a superior solution in this dimension.
Innovation
HeartFlow AnalysisHeartFlow's application of Computational Fluid Dynamics (CFD) to derive Fractional Flow Reserve (FFRct) from standard CT scans, along with AI-powered 3D modeling and plaque characterization, represents a highly sophisticated and innovative use of technology to provide non-invasive physiological insights. While Viz RV/LV's automated measurements and alerts are valuable, HeartFlow's core technology for blood flow simulation is arguably more groundbreaking in its scientific complexity and depth of insight.
Support & Docs
TieBoth HeartFlow and Viz.ai appear to offer robust support and documentation, including comprehensive training, technical support, and educational resources for clinicians. The descriptions of their support offerings are similar in scope, making it difficult to distinguish a clear winner without more granular details on the quality or depth of these services.
Feature-by-Feature
Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.
| Feature | HeartFlow Analysis | Viz RV/LV |
|---|---|---|
| Primary Diagnostic Focus | Diagnosing and managing coronary artery disease (CAD) by creating personalized 3D models of patients' coronary arteries from standard CT scans. | Automates right and left ventricular diameter measurements from CTPA scans, providing a crucial RV/LV ratio for rapid pulmonary embolism risk stratification. |
| Company | HeartFlow | Viz.ai |
| Key AI-Powered Analysis | AI-powered 3D modeling of coronary arteries; Fractional Flow Reserve derived from CT (FFRct) analysis; Plaque Analysis (quantification and characterization); Computational Fluid Dynamics (CFD) for blood flow simulation. | Automated Right Ventricle (RV) to Left Ventricle (LV) ratio measurement; Analysis of volumetric CTPA acquisitions; AI algorithm for identification and measurement of heart ventricles. |
| Target Medical Specialties | Cardiology, Radiology | Emergency Medicine, Pulmonology, Radiology |
Videos
Demos, reviews, and walkthroughs featuring HeartFlow Analysis and Viz RV/LV.
Frequently Asked Questions
More Comparisons
More matchups featuring HeartFlow Analysis or Viz RV/LV
Backers
Who funded each tool's parent company.